MedPath

Evaluation of TTE Utilization in Medical Surgery Step-Down Unit

Conditions
Cardiac Disease
Registration Number
NCT04203251
Lead Sponsor
Caption Health, Inc.
Brief Summary

This is a non-randomized, un-blinded study to evaluate Caption Health guidance software in patients in the medical surgery step-down unit. Patients will be scanned by a trained hospitalist and up to 4 standard views will be obtained per participant: PLAX, PSAX-PM, AP4 and SubC4. Observations will be made regarding human factors and performance of the device.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

.

  • Patients β‰₯18 years old
  • Patients in the medical surgery step-down clinical setting
  • Patients who consent to participating in the study
Exclusion Criteria

.

  • ● Patients with emergent or urgent episodes of injury and illness that can lead to death or disability without rapid intervention

    • Unable to lie flat for study
    • Patients experiencing a known or suspected acute cardiac event at the time of evaluation
    • Patients with severe chest wall abnormalities
    • Patients who have undergone pneumonectomy
    • Patients with recent abdominal surgery
    • Patients unwilling or unable to give written informed consent
    • Principal Investigator determination to exclude the subject from participation
    • Investigators also have the right to withdraw patient from the study in the event of illness, adverse events, or other reasons concerning the health or well-being of the patient, or in the case of non-compliance.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of attempted studies with clinically useful imagesUp to 3 Months

Compare the percentage of clinically useful versus not useful images

Mean time to acquire imagesUp to 3 months

Assess the time to acquire cardiac ultrasound images with and without Caption AI Gudiance

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of California San Francisco

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

Β© Copyright 2025. All Rights Reserved by MedPath